A clinical trial has begun which will use stem cell transplants to grow a new immune system for people with untreatable Crohn’s disease – a painful and chronic intestinal disease which affects at least 115,000 people in the UK.
The study, led by Queen Mary University of London and Barts Health NHS Trust, is funded with £2m from a Medical Research Council and National Institute for Health Research partnership, and will be recruiting patients from centres in Cambridge, Edinburgh, Liverpool, London, Nottingham, Oxford and Sheffield. The trial is coordinated through the Clinical Trials Unit at the University of Sheffield.
Crohn’s disease is a long-term condition that causes inflammation of the lining of the digestive system, and results in diarrhoea, abdominal pain, extreme tiredness and other symptoms that significantly affect quality of life.
Current treatments include drugs to reduce inflammation but these have varying results, and surgery is often needed to remove the affected part of the bowel. In extreme cases, after multiple operations over the years, patients may require a final operation to divert the bowel from the anus to an opening in the stomach, called a stoma, where stools are collected in a pouch.
‘We might be able to radically alter the course of the disease’
Chief investigator Professor James Lindsay from Queen Mary’s Blizard Institute and a consultant at Barts Health NHS Trust said: “Despite the introduction of new drugs, there are still many patients who don’t respond, or gradually lose response, to all available treatments. Although surgery with the formation of a stoma may be an option that allows patients to return to normal daily activities, it is not suitable in some and others may not want to consider this approach.
“We’re hoping that by completely resetting the patient’s immune system through a stem cell transplant, we might be able to radically alter the course of the disease. While it may not be a cure, it may allow some patients to finally respond to drugs which previously did not work.”
Helen Bartlett, a Crohn’s disease patient who had stem cell therapy at John Radcliffe Hospital, Oxford, said: “Living with Crohn’s is a daily struggle. You go to the toilet so often, you bleed a lot and it’s incredibly tiring. You also always need to be careful about where you go. I’ve had to get off trains before because there’s been no toilet, and I needed to go there and then.
“I’ve been in and out of hospital for the last twenty years, operation after operation, drug after drug, to try to beat this disease. It’s frustrating, it’s depressing and you just feel so low.
“When offered the stem cell transplant, it was a complete no brainer as I didn’t want to go through yet more failed operations. I cannot describe how much better I feel since the treatment. I still have problems and I’m always going to have problems, but I’m not in that constant pain.”
Giving patients a new immune system
The Latest on: Crohn’s disease
via Google News
The Latest on: Crohn’s disease
New clinical trial treats Crohn’s disease with diet
on August 17, 2018 at 7:32 am
More than three million Americans suffer from Crohn's disease. It can have a profound impact on a patient's quality of life, and a new clinical trial aims to bring some relief. It's enrolling particip... […]
Now We Understand How Marijuana Makes Inflammatory Bowel Disease Bearable
on August 14, 2018 at 10:57 am
People who live with inflammatory bowel disease deal with a lot of physical discomfort, and for some reason cannabis seems to give them relief. IBD, which includes conditions like ulcerative colitis a... […]
RedHill Biopharma Receives Allowance for New U.S. Patent Covering RHB-104 for Crohn’s Disease and RHB-204 for NTM Infections
on August 13, 2018 at 2:51 pm
Once granted, the new patent, which covers both RHB-104 and RHB-204, is expected to be valid until at least 2029 RedHill recently announced positive top-line results from the randomized, double-blind, ... […]
Cannabis Could Treat Colitis and Crohn's Disease, Study in Mice Suggests
on August 13, 2018 at 1:00 pm
Cannabis could ease the symptoms of inflammatory bowel disease (IBD), according to research in mice. Marijuana is already used to treat a range of conditions, from pain and nausea to mental disorders ... […]
RedHill Biopharma (RDHL) Reports Allowance for New U.S. Patent Covering RHB-104 for Crohn’s Disease and RHB-204 for NTM Infections
on August 13, 2018 at 4:03 am
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. Danielle Abramson, Ph.D., RedHill’s Vice President, Intellectual Property & R... […]
Crohn's Disease Treatment Market - Global Forecast to 2026
on August 10, 2018 at 8:09 am
Crohn’s disease is a form of inflammatory bowel disease (IBD) that refers to a chronic inflammatory condition of the gastrointestinal tract causing inflammation in the digestive tract. The disease is ... […]
Albert Lea bowler who overcame Crohn's Disease set to make first professional appearance
on August 8, 2018 at 7:00 am
Mariah Jacobson grew up constantly around a bowling alley. From the time she was in elementary school, Jacobson remembers spending countless hours near the lanes with her family, especially her mother ... […]
Crohn's and Colitis Canada awards $2.7 million in new grants to researchers across Canada
on August 7, 2018 at 6:00 am
2018 /CNW/ - Crohn's and Colitis Canada demonstrates its ongoing commitment to discovering cures for Crohn's disease and ulcerative colitis as it announces an investment in innovative research through ... […]
Rebooting the immune system with stem cell transplants trialed for Crohn's disease
on August 6, 2018 at 8:02 pm
A large trial has just been launched in the UK exploring the use of stem cells for treating patients with Crohn's disease. The radical treatment involves essentially "rebooting" a patient's immune sys... […]
via Bing News